Navigation Links
Symbiotic bacteria protect hunting wasps from fungal infestation

Researchers have discovered a fascinating symbiotic relationship between a wasp species and a newly discovered bacterial species ?a relationship that potentially sheds light on how bacteria can be successfully utilized by higher organisms in defensive mechanisms against other microbes. In the new work, researchers show that a solitary ground-nesting wasp, the European beewolf, harbors Streptomyces bacteria in unique structures within its antennae and that females utilize these bacterial symbionts to protect the wasp larvae against pathogenic fungi.

Detrimental microorganisms are a permanent threat to higher organisms, and because of their high reproductive potential and adaptability, they are extremely difficult to control. Ironically, the best counteragents against microbes are often other microbes that produce very potent antibiotics. Thus, an effective and elegant way to counter the threat caused by bacteria and fungi is to establish a symbiotic relationship with innocuous antibiotic-producing bacteria that provide protection against the most dangerous pathogens. As yet, only a few cases of defensive symbioses between higher organisms and bacteria have been reported.

In their new paper, Martin Kaltenpoth and his colleagues at the Biocenter of the University of Würzburg show that the European beewolf Philanthus triangulum has evolved a defensive symbiosis with a new species of bacteria of the genus Streptomyces. Interestingly, this genus comprises the most important group of bacteria for the production of antibiotics for human medicine.

Female beewolves provision their larvae with paralyzed honeybees in brood cells in the soil. As part of this process, the researchers show, they use their antennae to deliver the symbiotic bacteria to the ceiling of the brood cell before finally closing off the cell. The larvae then take up the bacteria and apply them to the silk threads of their cocoons. The researchers found that experimental removal of the
'"/>

Source:Cell Press


Page: 1 2

Related biology news :

1. Anti-bacterial additive widespread in U.S. waterways
2. A bacterial genome reveals new targets to combat infectious disease
3. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
4. Scientists discover that host cell lipids facilitate bacterial movement
5. Family trees of ancient bacteria reveal evolutionary moves
6. Drug-resistant bacteria on poultry products differ by brand
7. Programmable cells: Engineer turns bacteria into living computers
8. NASA links nanobacteria to kidney stones and other diseases
9. Substance protects resilient staph bacteria
10. Physiological effects of reduced gravity on bacteria
11. Anammox bacteria produce nitrogen gas in oceans snackbar

Post Your Comments:
(Date:12/3/2009)...olar panels that repels grime and dirt? Expanded b...r? New Tel Aviv University research, just publishe...gh in assembling peptides at the nano-scale level ... in just a few years. , Operating in the range o...) and even smaller, graduate student Lihi Adler-Ab...
(Date:12/3/2009)... a personality change in warmer water, according t...change may make some species more aggressive. , ...n Australia,s Great Barrier Reef have shown for th...tently timid, or consistently bold, and that these...ter temperatures rise. , A slight lift of just o...
(Date:12/3/2009)...ists from the U.S. Department of Energy,s (DOE) Br...and the Indian Institute of Science has made a maj...genetic information in DNA that is necessary to ca...ch, published in the December 1, 2009 edition of ...hat many proteins responsible for interacting at s...
Breaking Biology News(10 mins):A window that washes itself? 2Fish with attitude: Some like it hot 2Grooving down the helix 2Grooving down the helix 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 1Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 2Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 3Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease 4733 4Long Term Care 3A The Next Big Womens Issue 3F 51873 1Long Term Care 3A The Next Big Womens Issue 3F 51873 2Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2
... The General Services Administration (GSA) has cer... a provider of Personal Identity Verification (PIV...managed services, under Homeland Security Presiden...on, ABBTECH will offer services through their GSA ...n approved service provider. Services provided b...
...l 3, 2009 -- By identifying a novel compound that ... Ridge National Laboratory and the University of C...stant plants. , In a paper published in Science ...artment of Energy,s ORNL reports that azelaic acid...abidopsis, a small flowering plant related to cabb...
...itor of Playboy magazine, has won the 2009 Media A...ces (AIBS), given to a journalist for outstanding ...r broadcast journalism. Rowe,s story, "Sexual Male... the magazine on scientists, findings during the p...lopment. This segment of the series appeared in th...
Other Biology News:ABBTECH Staffing Services Certified by GSA as an HSPD-12 Managed Service Provider 2Researchers discover primer to plant defense system 22009 AIBS Media Award 22009 AIBS Media Award 3
(Date:12/3/2009)..., , PHILADELPHIA, Dec. 3 /PRNewswire-Fir...the global specialty biopharmaceutical company, to...voluntary market withdrawal of one lot of the Atte...Daytrana ® . Shire is taking this action beca...ture may not meet their release liner removal spec...
(Date:12/3/2009)..., , NEW DELHI, India, Dec. 3 ...,Chief Science Officer at Shenzhen Beike Biotechno...oke at a conference on High-Risk Diabetic,Foot Car... China,s leading,stem cell research and regenerati...ganized by the Indian Podiatry Association (IPA), ...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 /PRNewswire/ ...search report is available in its catalogue: ,,...ective ,, http://www.reportlinker.com/p016436...ective.html ,, Incubators are the most critic...r, research, and other applications for providing ...
(Date:12/2/2009)..., , TUSTIN, Calif., Dec. 2 /PRNewswire...sdaq: PPHM ) today reported completion of patient...rial of Cotara® in patients with relapsed gli...brain cancer. Cotara is a targeted monoclonal ant...a potential new treatment for GBM. Cotara specifi...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...sdaq: FOLD ) will announce third quarter 2008 fin...on Monday, November 3, 2008. The results,announcem... webcast that,afternoon at 5 p.m. ET., Interested...nce call at,5 p.m. ET by dialing 877-419-6591 (U.S...honic replay of the call will be available for,sev...
...Eastern Time Today to D...st,Pharmaceuticals, Inc. (Nasdaq: BCRX ) today an... intravenous (i.v.) peramivir, a neuraminidase,inh... or potentially,life-threatening influenza. The Ph...ve days of therapy with either 200 mg i.v. peramiv...
...tivities, enhancement in research investment from ...of user-friendly products is likely to propel the ...tic and manual, to reach $315 million by 2015. , ...B) October 27, 2008 -- Titration is one of the mos...he chemical composition of laboratory and industri...
Other Biology Technology:Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 2BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 3BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 4BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 5BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza 6Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 2Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc. 3
...98C679.2.1] to Presenilin 2 Alzheimer's disease (... carry mutations in the presenilin proteins (PSEN1...hese disease-linked mutations result in increased ...n component of amyloid deposits found in AD brains...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: